Thymosin alpha-1 is a 28-amino-acid peptide produced by the thymus. It is approved as a medicine in a number of countries outside the United States and has a substantial clinical literature; in the United States it is available only as a compounded preparation, which is not FDA-approved. Offered for immune support in healthy adults, not to treat any infection or immune disorder.

Members 45+ adding immune support to a longevity protocol.

• Studied for T-cell and immune signalling
• Substantial international clinical literature
• Twice-weekly dosing
• Commonly run seasonally rather than continuously

• 12 weeks of compounded Thymosin Alpha-1 (2 mg/mL, 5 mL vial)
• Reconstitution kit
• Insulin syringes + alcohol prep pads
• Protocol check-in at week 6

POSSIBLE SIDE EFFECTS

• Injection-site redness or soreness
• Transient flu-like feeling after the first doses
• Fatigue
• Joint aches

DO NOT USE IF

• Organ transplant, or any immunosuppressive therapy
• Autoimmune disease — the mechanism is immune stimulation
• Pregnancy or breastfeeding
• Known hypersensitivity to the preparation

Not exhaustive and not medical advice. Talk to your own healthcare provider about your history and medications before starting.

Delivery

Subcutaneous

Cycle length

12-week cycle

Category

Longevity

Storage

Refrigerated 2–8°C · use within compounding date

Third-party tested

Yes

Cold-chain shipped from our licensed 503A pharmacy in temperature- controlled packaging. Free shipping on every cycle. Tracking available in your portal once your order ships.